The following Industry Symposia will be organised by our Platinum Sponsors.
All congress participants are invited to join those symposia!
Industry Symposium 1
organised by Alexion, AstraZeneca Rare Disease
Friday, November 13, 2026
12:00-13:00
Lecture Hall 1 + 2 combined
Clinical evidence and expert insights on the management of NF1-PN
Dr. Said Farschtschi, Universitätsklinikum Hamburg-Eppendorf
Dr. João Passos, Instituto Português De Oncologia De Lisboa Francisco Gentil, E.p.e.
Chair: Dr. Alice Chen, National Cancer Institute
Industry Symposium 2
organised by MERCK
Saturday, November 14, 2026
12:00-13:00
Lecture Hall 1 with overflow into Lecture Hall 2
CARE FOR RARE: NF1-PN management in practice: a focus on pain, evidence, and clinical cases.
Andrea Franson, University of Michigan, Ann Arbor, USA
Dusica Babovic-Vuksanovic, Mayo Clinic, Rochester, USA
Chair: Ignacio Blanco, Germans Trias i Pujol University Hospital, Barcelona, Spain
The 2026 European Neurofibromatosis Conference in Vienna (12–14 November) is now fully booked. Explore advances in NF1, Schwannomatosis, and patient-centred research at Hyatt Regency Vienna (previously Andaz Vienna Am Belvedere).